A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

NCT01384435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

SCD

Interventions

DRUG: KPS-0373
DRUG: KPS-0373
DRUG: KPS-0373
DRUG: KPS-0373
DRUG: Placebo

Sponsor

Kissei Pharmaceutical Co., Ltd.